GLI1 and esophageal squamous cell carcinoma: VS‐4718 (1 μM) inhibited the activation of AKT and the interaction between AKT and Gli1 in indicated ESCC cells harbored AKT wt, but not significantly suppressed those of AKT S473/T308D (Figure 3F and Figure S10B,C).